| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $297.9M | -6.1% |
| Cost of Revenue | $96.4M | -7.1% |
| Gross Profit | $201.5M | -5.7% |
| R&D Expense | $49.4M | +6.9% |
| SG&A Expense | $61.3M | -13.1% |
| Operating Income | -$163.9M | -307.5% |
| Pre-tax Income | -$182.4M | -160.0% |
| Income Tax | -$2.5M | -43.2% |
| Net Income | -$179.9M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $236.6M | -4.9% |
| Accounts Receivable | $38.8M | -18.6% |
| Current Assets | $300.2M | -6.6% |
| Total Assets | $870.0M | -21.9% |
| Current Liabilities | $130.6M | -13.6% |
| Long-term Debt | $476.7M | -7.4% |
| Total Liabilities | $626.1M | -9.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $49.9M | +66.6% |
| Capital Expenditures | $1.2M | +40.9% |
| Investing Cash Flow | -$1.2M | +98.1% |
| Financing Cash Flow | -$61.4M | -165.2% |
| Free Cash Flow | $48.7M | +67.4% |
| -162.9% |
| EPS (Basic) | -$5.77 | -158.7% |
| EPS (Diluted) | -$5.77 | -158.7% |
| Stockholders' Equity |
| $126.3M |
| -59.1% |